Surrey Heartlands

Joint Formulary & PAD

Cyclopentolate hydrochloride - Iritis

You are here : Home > Formulary Search > Cyclopentolate hydrochloride - Iritis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Eye drops
  • Eye drops (preservative free
  • unit dose)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
eye drops 0.5%, 1%

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Cyclopentolate hydrochloride
Indication :
Iritis
Group Name :
Keywords :
eye drops, minims
Brand Names Include :
Mydrilate
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Cyclopentolate hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Iritis.

Committee Recommendations (1)

05 Sep 18 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Prescribing Clinical Network recommends the use of cyclopentolate eye drops (0.5% & 1%) for the treatment licensed hospital indications ( including Iritis and Uveitis)

Cyclopentolate eye drops will be considered to be RED on the traffic light system.

New patients should be initiated on cyclopentolate eye drops by their consultant ophthalmologist.